The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression

Schraeder, Tobias; Dudek, Sabine E.; Schreiber, Andre; Ehrhardt, Christina; Planz, Oliver; Ludwig, Stephan

dc.contributor.author	Planz, Oliver
dc.date.accessioned	2019-08-17T11:23:33Z
dc.date.available	2019-08-17T11:23:33Z
dc.date.issued	2018
dc.identifier.issn	1872-9096
dc.identifier.uri	http://hdl.handle.net/10900/91591
dc.language.iso	en	en
dc.publisher	Elsevier Science Bv	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.antiviral.2018.07.006
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_01389
utue.publikation.seiten	80-92	de_DE
utue.personen.roh	Schraeder, Tobias
utue.personen.roh	Dudek, Sabine E.
utue.personen.roh	Schreiber, Andre
utue.personen.roh	Ehrhardt, Christina
utue.personen.roh	Planz, Oliver
utue.personen.roh	Ludwig, Stephan
dcterms.isPartOf.ZSTitelID	Antiviral Research	de_DE
dcterms.isPartOf.ZS-Volume	157	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät
utue.fakultaet	Sonstige